Postgraduate Year Two (PGY2)


PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Description

The oncology residency program at the Huntsman Cancer Institute (HCI) at the University of Utah is an intensive one-year clinical training program. HCI is an academic National Cancer Institute (NCI)-designated comprehensive cancer center and National Comprehensive Cancer Center (NCCN) member institution. The resident will develop an extensive knowledge base and problem-solving skills through an array of clinical experiences in acute and ambulatory care settings. The resident will be involved in maintaining and improving oncology practice by providing pharmacy services in various areas. Upon completion of the residency, the resident will be well prepared to practice in a variety of oncology settings. The program is accredited by the American Society of Health-System Pharmacists.

Program Aims

  • Demonstrate a high level of professional responsibility, dedication, skill and maturity to practice in an oncology clinical environment.
  • Develop a working knowledge of the biology of neoplasia which is evolving medication therapy in the field of oncology.
  • Attain a level of didactic knowledge that will enable the resident to pass the Board Certified Oncology Pharmacist (BCOP) exam (with further study of at least statistics, drug literature evaluation, practice management, public health and advocacy concepts likely necessary).
  • Serve as a role model and instructor for undergraduate and graduate students, and for practicing pharmacists.
  • Demonstrate the motivation and responsibility for self-directed, independent study and learning.
  • Clearly, concisely, effectively, and appropriately communicate, both verbally and in writing, with health care professionals and with patients.
  • Develop a skill set of practice that assures competent practice in a variety of oncology settings.

Rotation Experiences

Required experiences include inpatient hematology, oncology, and blood & marrow transplant; outpatient solid tumor clinic, oncology infusion, infectious diseases; and abbreviated rotations in investigational drug services and management. Electives include oncology-specific intensive care, numerous hematology/oncology/BMT clinics, pain and palliative care, pediatric oncology and stem cell transplant, and many others. See here for further rotation information. See also here for a sample of resident scheduling possibilities, and here for a list of oncology-specific pharmacists.

Teaching & Learning Opportunities

The resident will lead a variety of weekly formal topic discussions (6 per resident, in addition to topic discussions on rotation) with associated drug reviews. Each resident will prepare content for both the college of pharmacy oncology pharmacotherapeutics module and the new oncology elective course, and is allowed to participate in additional lecture and/or recitation opportunities if interested. Residents participate in monthly discussions regarding the biology of cancer with our medical fellows through a review of a biology of cancer textbook. Each resident will prepare and present a 1-hour ACPE-accredited continuing education program. Additional opportunities are available through student and resident precepting and/or mentoring, multidisciplinary in-services, oncology fellows’ conferences, journal clubs, and an optional teaching certificate program.

Service Commitment

Each resident will function in a staff pharmacist capacity in both centralized and decentralized areas on an average of 4 shifts per month. Areas that the resident will staff include inpatient hematology, oncology, and stem cell transplant; infusion; and central pharmacy. Additional areas may be included based on resident interest and departmental needs. Residents are required to staff a portion of observed holidays. Participation in various community volunteer opportunities is encouraged, but not required.

Professional Meetings

All University of Utah residents are expected to attend the ASHP Midyear Clinical Meeting in December and Mountain States Conference in May. PGY2 Oncology residents are also encouraged to attend the HOPA Annual Meeting in March.

Residency Project

Each resident will choose a project idea either of their own creation or as presented by a preceptor as long as the project aligns with our institutional strategic plan and departmental goals, or improves patient care by either answering a clinical question or developing new pharmacy services. All ideas will be vetted through the research subcommittee. Each project will be presented in poster form at the annual Vizient (UHC) meeting prior to Midyear, with an additional optional poster presentation at the HOPA annual meeting. Each resident will present their project findings as a platform presentation at the Mountain States Conference and prepare a manuscript suitable for publication in an appropriate journal.


Candidates must graduate from an ACPE-accredited pharmacy program with a doctor of pharmacy degree (or equivalent combination of education and clinical experience). Minimum GPA is not required as for other programs, but is taken into consideration. Residents must also have completed an ASHP-accredited PGY1 pharmacy residency program. Applicants must be eligible for Utah licensure and are expected to obtain licensure as a pharmacist in Utah by September 30th of each program year. The University of Utah Pharmacy residency programs do not sponsor visas.

Recruitment and Selection

The following information must be submitted by the date specified (typically the first Friday in January) in the Pharmacy Online Residency Centralized Application Service (PhORCAS) for the applicant to be considered for an on-site interview:

  • Completed PhORCAS registration
  • Curriculum vitae
  • Letter of intent
  • College of pharmacy transcripts
  • Three recommendations using the PhORCAS standard form

All residency programs at University of Utah Health use PhORCAS for application review and do not accept paper applications. Completed applications in PhORCAS are reviewed, and competitive applicants are invited to attend an on-site, full-day interview in January, February, or March. The program participates in the National Matching Service through ASHP.

For more information contact:

Stephanie A. Sanders, BS, PharmD, BCOP
Residency Program Director, PGY2 Oncology
Clinical Pharmacist, Oncology Intensive Care
Adjunct Instructor, College of Pharmacy
(801) 213-4293
Sara Hiller deHoll, PharmD, BCOP
Residency Coordinator, PGY2 Oncology
Clinical Pharmacist, Inpatient
Hematology & Oncology Clinics
Adjunct Instructor, College of Pharmacy
(801) 213-4293

Updated November 2019



Sara deHoll, BCOP

Contact Us

Questions? Call us: